If you look at Bots own investor presentations on 28/02/23 they say 3.7m axillary actively seeking treatment, and another 7.3m axillary not seeking treatment. They also claim a market size of ~$1.6 billion.
They have a source on the bottom of the page "Source: 1. Doolittle, J. et al. Arch Dermatol Res, 2016. 2. Hamm H. et al. Dermatology. 2006."
if you divide 1.6 billion by 3.7 million you get $432 spent by each person actively seeking treatment.
No idea if that's actually reality, and who's right or wrong.
BOT - Anything but charting, page-5537
-
- There are more pages in this discussion • 4,160 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
37.0¢ |
Change
-0.010(2.63%) |
Mkt cap ! $669.7M | |||
| Open | High | Low | Value | Volume |
| 38.0¢ | 38.5¢ | 36.5¢ | $2.548M | 6.766M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 96148 | 36.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.0¢ | 782479 | 9 |
View Market Depth
| Last trade - 16.10pm 16/08/2024 (20 minute delay) ? |
| BOT (ASX) Chart |